Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02276677 · ClinicalTrials.gov registry record · Early Phase 1

Oxytocin Effects on Food Motivation Pathways

A Early Phase 1 study of Overweight and Obesity, sponsored by Massachusetts General Hospital.

Completed
Registry status
Early Phase 1
Development phase
10
Enrollment target
1
Study location

NCT02276677 is a Early Phase 1 study of Overweight and Obesity that has completed, run by Massachusetts General Hospital. The registered enrollment target is 10 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02276677, a Early Phase 1 study of Overweight and Obesity, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
Early Phase 1
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Oxytocin is a peptide hormone produced in the brain that regulates food intake. However, the mechanisms for this effect in humans is not yet clear. In this study, the investigators will therefore examine the effect of a single dose of intranasal oxytocin (compared to placebo) on levels of appetite-regulating hormones and functional magnetic resonance imaging activation of areas of the brain involved in food motivation.

Conditions Studied

Overweight and Obesity

Interventions

  • DRUG Placebo
  • DRUG Oxytocin

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2014-10
Est. Completion 2015-05
Phase Early Phase 1

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02276677

The ClinicalTrials.gov registry entry for NCT02276677 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (96% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT02276677 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02276677 about?

NCT02276677 is a clinical study titled "Oxytocin Effects on Food Motivation Pathways". Oxytocin is a peptide hormone produced in the brain that regulates food intake. However, the mechanisms for this effect in humans is not yet clear. In this study, the investigators will therefore examine the effect of a single dose of intranasal oxytocin (compared to placebo) on levels of appetite-...

What is the current status of trial NCT02276677?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2014-10. Estimated completion is 2015-05.

What conditions does trial NCT02276677 study?

This clinical trial studies the following conditions: Overweight and Obesity.

What interventions are being tested in trial NCT02276677?

The interventions under investigation include: Placebo (DRUG), Oxytocin (DRUG).

Who is sponsoring clinical trial NCT02276677?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02276677 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Overweight and Obesity

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.